Literature DB >> 21447089

Identification of the STAT5B-RARα fusion transcript in an acute promyelocytic leukemia patient without FLT3, NPM1, c-Kit and C/EBPα mutation.

Chun Qiao1, Su-Jiang Zhang, Li-Juan Chen, Kou-Rong Miao, Jian-Fu Zhang, Yu-Jie Wu, Hai-Rong Qiu, Jian-Yong Li.   

Abstract

T(15;17) is the most common chromosomal aberration in patients with acute promyelocytic leukemia (APL), leading to the formation of PML-RARα fusion gene. In a small subset of patients with APL, the RARα gene is fused with different partners. Here, we report a rare APL case with STAT5B-RARα fusion transcript. Cytomorphologic and immunophenotypic analyses showed typical features of APL. However, cytogenetic analysis showed normal karyotype, and interphase fluorescence in situ hybridization (FISH) showed PML-RARα negative. Quantitative RT-PCR also showed PML-RARα negative but STAT5B-RARα positive and sequencing analysis confirmed the result. Molecular markers including FLT3, NPM1, c-Kit and C/EBPα mutation were all negative. To our knowledge, this is the first APL patient with STAT5B-RARα in Chinese population and the fifth patient around the world according to published paper.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447089     DOI: 10.1111/j.1600-0609.2011.01595.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

1.  Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia.

Authors:  Yuan-Dong Zhu; Li Wang; Chao Sun; Lei Fan; Dan-Xia Zhu; Cheng Fang; Yin-Hua Wang; Zhi-Jian Zou; Su-Jiang Zhang; Jian-Yong Li; Wei Xu
Journal:  Med Oncol       Date:  2011-12-31       Impact factor: 3.064

2.  Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia.

Authors:  Jelena V Jovanovic; Kristian Rennie; Dominic Culligan; Andrew Peniket; Anne Lennard; Justin Harrison; Paresh Vyas; David Grimwade
Journal:  Front Oncol       Date:  2011-10-25       Impact factor: 6.244

Review 3.  Characterization of atypical acute promyelocytic leukaemia: Three cases report and literature review.

Authors:  Xiaoxue Wang; Jing Wang; Lijun Zhang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 4.  PLZF-RARα, NPM1-RARα, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.

Authors:  Marta Sobas; Maria Carme Talarn-Forcadell; David Martínez-Cuadrón; Lourdes Escoda; María J García-Pérez; Jose Mariz; María J Mela-Osorio; Isolda Fernández; Juan M Alonso-Domínguez; Javier Cornago-Navascués; Gabriela Rodríguez-Macias; María E Amutio; Carlos Rodríguez-Medina; Jordi Esteve; Agnieszka Sokół; Thais Murciano-Carrillo; María J Calasanz; Manuel Barrios; Eva Barragán; Miguel A Sanz; Pau Montesinos
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

Review 5.  Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.

Authors:  Luca Guarnera; Tiziana Ottone; Emiliano Fabiani; Mariadomenica Divona; Arianna Savi; Serena Travaglini; Giulia Falconi; Paola Panetta; Maria Cristina Rapanotti; Maria Teresa Voso
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

Review 6.  Does acute promyelocytic leukemia patient with the STAT5B/RARa fusion gene respond well to decitabine?: A case report and literature review.

Authors:  Lei Wang; Xiaojing Yan; Juan He
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.